Published Date: 13 Mar 2023
Among other things, international students seek connections and advice on how to better compete by supporting community groups.
Read Full NewsResearchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.
Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.
For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.
Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.
1.
Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.
2.
Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.
3.
Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.
4.
Canadian Group Calls for Earlier Colorectal Cancer Screening
5.
AI tool identifies women at high risk of interval breast cancer
1.
An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients
2.
The Capmist DM: A Revolutionary Way to Combat Dry Mouth
3.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
4.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
5.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Lung Cancer Congress®
3.
Genito-Urinary Oncology Summit 2026
4.
Future NRG Oncology Meeting
5.
ISMB 2026 (Intelligent Systems for Molecular Biology)
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation